INVO Fertility FY2025 revenue rises 5% on clinic acquisition

INVO Fertility

02/06/2026 13:46

Overview
US fertility clinic operator's FY2025 revenue grew 5% yr/yr
Net loss from continuing operations narrowed to $5.3 mln from $7.7 mln
Company closed Indiana clinic acquisition and expanded employer-benefit access

Outlook
Company says it is focused on driving organic growth across existing clinics and integrating acquisitions
INVO Fertility expects favorable long-term demand trends and expanding employer-benefit coverage to support growth
Company says it has a robust acquisition pipeline and improved balance sheet to support future expansion

Result Drivers
CLINIC ACQUISITION - Co said revenue growth was supported by the acquisition of Indiana-based Family Beginnings clinic in February 2026
EMPLOYER-BENEFIT ACCESS - Wisconsin Fertility Institute joined the Progyny network, broadening access to employer-sponsored patients and strengthening payor mix
ORGANIC GROWTH INITIATIVES - New initiatives at Atlanta clinic since March 2026 are having meaningful impact, per company

Company press release: ID:nGNX76j8Hk

Key Details
Metric
Beat/Miss
Actual
Consensus Estimate
Q1 Revenue
 
$6.84 mln
 

Analyst Coverage
The one available analyst rating on the shares is "buy"
The average consensus recommendation for the medical equipment, supplies & distribution peer group is "buy"
Wall Street's median 12-month price target for INVO Fertility Inc is $20.00, about 1,260.5% above its June 1 closing price of $1.47

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.

Press Release s3://eap-prd-eu-west-1-source-content/eap_feed_proxy/ucdp/news_glbnwr/2026-06-02/fee07a39-b9d3-489b-a35c-30b6795249ff.json
 (This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)